SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-22-000042
Filing Date
2022-05-05
Accepted
2022-05-05 07:04:52
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20220331.htm   iXBRL 10-Q 1344565
2 EX-31.1 q12022exhibit311.htm EX-31.1 10675
3 EX-31.2 q12022exhibit312.htm EX-31.2 10641
4 EX-32.1 q12022exhibit321.htm EX-32.1 6149
5 EX-32.2 q12022exhibit322.htm EX-32.2 6074
  Complete submission text file 0001367920-22-000042.txt   5934169

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20220331.xsd EX-101.SCH 38721
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20220331_cal.xml EX-101.CAL 52029
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20220331_def.xml EX-101.DEF 195717
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20220331_lab.xml EX-101.LAB 529988
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20220331_pre.xml EX-101.PRE 344517
58 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20220331_htm.xml XML 847506
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 22893980
SIC: 2834 Pharmaceutical Preparations